Trials / Unknown
UnknownNCT06165874
[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Huashan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to establish and optimize the imaging method of \[68Ga\]Ga-NOTA-RW102, as well as its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agent was evaluated in patients with non-small cell lung cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | [68Ga]Ga-NOTA-RW102 PET Imaging | Intravenous injection of 1.8 MBq\[0.05MCi\]/kg of \[68Ga\]Ga-NOTA-RW102 in a single dose. |
Timeline
- Start date
- 2023-03-12
- Primary completion
- 2023-10-13
- Completion
- 2024-01-14
- First posted
- 2023-12-12
- Last updated
- 2023-12-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06165874. Inclusion in this directory is not an endorsement.